🔵 RESEARCH
SAFE-AI Trial Tests Multimodal GenAI for GI Cancer Recurrence Detection
A clinical trial will build and validate multimodal GenAI combining MRI/PET, serum markers, and genomics to detect minimal residual disease in GI oncology.
Current single-modality tools miss early recurrence in many GI cancer patients. This trial's fusion of imaging, molecular, and perioperative data could reshape post-surgical surveillance protocols if validated.
🔵 RESEARCH
Study Validates Doppler Ultrasound for Budd-Chiari Angioplasty Monitoring
European Radiology published a retrospective study validating Doppler ultrasound for evaluating angioplasty efficacy and predicting recurrence in Budd-Chiari syndrome.
For vascular imagers managing Budd-Chiari patients, this supports Doppler as a reliable, non-invasive tool for post-angioplasty surveillance — potentially reducing reliance on more costly cross-sectional follow-up.
🔵 RESEARCH
Deep Learning Framework Stratifies Grade 2 Breast Tumors on DCE-MRI
A European Radiology letter describes a deep learning framework using dynamic contrast-enhanced MRI to substratify Nottingham histologic grade 2 breast tumors.
Grade 2 breast tumors are notoriously heterogeneous in prognosis. AI-driven substratification on DCE-MRI could refine treatment planning and reduce both over- and under-treatment in this ambiguous group.
🔵 RESEARCH
Trial Develops 3D Ultrasound Brain Biomarkers for Preterm Infants
A clinical trial is developing quantitative 3D ultrasound biomarkers to predict neurodevelopmental outcomes in very preterm infants with white matter damage.
Cranial ultrasound remains the bedside standard in NICUs but lacks quantitative prognostic power. Validated 3D biomarkers could enable earlier intervention for at-risk neonates — adding to a week of expanding ultrasound applications.
🔵 RESEARCH
ACR Updates Appropriateness Criteria for Renovascular Hypertension
ACR published its 2026 update to imaging appropriateness criteria for evaluating renovascular hypertension, the most common cause of secondary hypertension.
Referring clinicians and radiologists now have refreshed, evidence-based guidance on modality selection for a condition affecting up to 5% of hypertensive patients — directly informing ordering patterns and protocol design.
🔵 RESEARCH
ACR Criteria Confirm Ultrasound as First-Line for Polycystic Kidney Disease
ACR appropriateness criteria designate ultrasound as the preferred initial imaging for autosomal dominant polycystic kidney disease, citing detection of cysts as small as 2–3 mm.
With MRI reserved as a sensitive alternative, this formal reaffirmation of ultrasound's primacy in ADPKD supports cost-effective screening pathways and reinforces ultrasound's role in nephrology imaging workflows.
🩺 EDITOR’S TAKE — FOR CLINICIANS
Two fresh ACR Appropriateness Criteria updates land today — review the renovascular hypertension and ADPKD guidance now, especially the reaffirmed primacy of ultrasound for initial ADPKD workup. These are immediate practice references.
📊 EDITOR’S TAKE — FOR INVESTORS
Multimodal GenAI trials fusing imaging with genomics and perioperative data signal growing demand for platforms that integrate across data types — a capability gap most pure-play imaging AI vendors have yet to fill.
🏭 EDITOR’S TAKE — FOR INDUSTRY
This week's ultrasound momentum — from wearable patches and therapy partnerships to neonatal 3D biomarkers and ADPKD guidelines — underscores ultrasound's expanding clinical footprint well beyond traditional radiology departments.